Risk behaviors after hepatitis C virus seroconversion in young injection drug users in San Francisco.
about
Cost effectiveness of screening strategies for early identification of HIV and HCV infection in injection drug usersIntimate injection partnerships are at elevated risk of high-risk injecting: a multi-level longitudinal study of HCV-serodiscordant injection partnerships in San Francisco, CAPreference, acceptability and implications of the rapid hepatitis C screening test among high-risk young people who inject drugs.Does the Strategy of Risk Group Testing for Hepatitis C Hit the Target?Hepatitis C virus risk behaviors within the partnerships of young injecting drug users.Risk Factors of Hepatitis C Virus Infection in Drug Users From Eleven Methadone Maintenance Treatment Clinics in Xi'an, ChinaPredictors and effects of alcohol use on liver function among young HCV-infected injection drug users in a behavioral intervention.Sustained drug use changes after hepatitis C screening and counseling among recently infected persons who inject drugs: a longitudinal study.A longitudinal study of hepatitis C virus testing and infection status notification on behaviour change in people who inject drugsPredictors of alcohol use among rural drug users after disclosure of hepatitis C virus status.Injection drug use and hepatitis C virus infection in young adult injectors: using evidence to inform comprehensive preventionExploratory social network analysis and gene sequencing in people who inject drugs infected with hepatitis C virus.Needle syringe programmes and opioid substitution therapy for preventing hepatitis C transmission in people who inject drugs.Insights on the Russian HCV Care Cascade: Minimal HCV Treatment for HIV/HCV Co-infected PWID in St. Petersburg.
P2860
Q28483820-3E23484B-AB37-4E16-BF9F-7617D79483C6Q28543558-4FED7BA5-69E8-4ED7-BD58-2C86253C92D4Q31168171-4F87968B-659B-48CE-ACE2-625B6DD28C52Q33858322-173A5AED-B281-4B6B-81D8-E3E623B42AC6Q34009271-52D8F428-E39B-4B58-9D85-E6E1F52B6AD6Q34864661-930129DE-F5A4-451C-B675-DB6EC0588586Q34981603-597E9FEE-5CBD-4AB6-B9C6-2E6EFBD88F87Q35074238-ABA5721E-42E3-4B55-988C-3C9FE440F801Q35889562-C72647C0-F67F-46BF-A02C-6C68B89F809DQ36698904-A22CF1F0-D71F-41FE-8EBC-68BD0AAC7531Q37042431-029C8370-8333-452A-BA0E-7477084D2E3EQ39609606-A774B17B-20CB-45CC-8277-0B6F41FD38E4Q42720607-5B71A5E2-52AB-4BEE-9B88-01FAF433B643Q52312138-9E1BE22F-E554-4FC7-BF2E-FB328FFFD1A5
P2860
Risk behaviors after hepatitis C virus seroconversion in young injection drug users in San Francisco.
description
2009 nî lūn-bûn
@nan
2009 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Risk behaviors after hepatitis ...... n drug users in San Francisco.
@ast
Risk behaviors after hepatitis ...... n drug users in San Francisco.
@en
type
label
Risk behaviors after hepatitis ...... n drug users in San Francisco.
@ast
Risk behaviors after hepatitis ...... n drug users in San Francisco.
@en
prefLabel
Risk behaviors after hepatitis ...... n drug users in San Francisco.
@ast
Risk behaviors after hepatitis ...... n drug users in San Francisco.
@en
P2860
P50
P1476
Risk behaviors after hepatitis ...... n drug users in San Francisco.
@en
P2093
Jennifer L Evans
Judith A Hahn
P2860
P304
P356
10.1016/J.DRUGALCDEP.2009.05.022
P577
2009-07-31T00:00:00Z